IRIDEX Corp risk profile

46 Elevated one input has moved against it

Measured 21 October 2026 from IRIX's filed statements. Recomputed nightly.

46 (Elevated), driven by Cash conversion at 89, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation83AcuteVolatileOne-year price volatility — 73.3%
Operating pressure26NormalWorseningCosts outgrowing revenue — 0.0 percentage points
Cash conversion89AcuteStableCapital spending against operating cash — -0.07x
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position40ElevatedStableR&D-intensity gap against peers — -74.6 percentage points
Concentration42ElevatedStableGeographic concentration — 3,309 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for IRIDEX Corp